Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.
Craig R CohenMichael R WierzbickiAudrey L FrenchSheldon MorrisSara NewmannHilary RenoLauri GreenSteve MillerJonathan PowellThomas ParksAnke HemmerlingPublished in: The New England journal of medicine (2020)
The use of Lactin-V after treatment with vaginal metronidazole resulted in a significantly lower incidence of recurrence of bacterial vaginosis than placebo at 12 weeks. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT02766023.).